News
It has been over 60 years since Osamu Shimomura et al. discovered Green Fluorescent Protein (GFP)1. Since then, the color ...
10d
News-Medical.Net on MSNFAM111B identified as a key driver of glioma progression and therapeutic targetGliomas are among the deadliest brain tumors, with limited treatment options and poor survival rates. Scientists from China ...
Gliomas are among the deadliest brain tumors, with limited treatment options and poor survival rates. Scientists from China ...
A team of researchers led by Prof. Jiang Changlong from the Hefei Institutes of Physical Science of the Chinese Academy of ...
Each time a cell divides, a small section of each chromosome's protective cap—the telomere—is worn away. Most cells use an ...
12d
AZoLifeSciences on MSNFluorescent Molecules Offer Unprecedented Insight into Cell StructuresScientists have long used fluorescent dyes—which emit light—to research cell structures and activities. By attaching ...
Optic gliomas stem from glial cells in your brain that function to support and nourish your brain’s neurons. They grow near your eye ’s optic nerve, the nerve that connects your eye to your brain.
Gliomas are among the most aggressive brain tumors, with glioblastoma offering a median survival of 12 to 15 months. Despite advances in surgical, ...
In Patients Receiving a Minimum of 55 mCi an Average 5.4 Months of PFS was Observed: Twice the Reported 2.25 MedianFLORHAM PARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc ...
After Decades Without Progress in Glioblastoma, Diakonos Stirs Up Interest in Dendritic Cell Vaccine
The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results